Trial intelligence / Profile preview

Imaging of Histone Deacetylase in the Heart

NCT03549559Recruiting

Sponsor
Massachusetts General Hospital
Start
Sep 2018
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of 11C-Martinostat in aortic valve stenosis and diabetes mellitus (DM) (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: 11C-Martinostat Binding. Started Sep 2018; status: recruiting.

02

Drugs

11C-Martinostat
03

Conditions

aortic valve stenosisdiabetes mellitus (DM)

Beyond the preview

Go deeper on NCT03549559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03549559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call